1. Republic of Korea Diabetes Care Devices Market Outlook to
2018- Glucose Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 86
Price: Single User License – US$2500
Republic of Korea Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin
Delivery
Summary
GlobalData’s new report, “Republic of Korea Diabetes Care Devices Market Outlook to 2018-
Glucose Monitoring and Insulin Delivery” provides key market data on the Republic of Korea
Diabetes Care Devices market. The report provides value (USD million), volume (units) and
average price (USD) data for each segment and sub-segment within two market categories –
Glucose Monitoring and Insulin Delivery. The report also provides company shares and
distribution shares data for each of the aforementioned market categories. The report is
supplemented with global corporate-level profiles of the key market participants with information
on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Republic of Korea Diabetes
Care Devicesmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Abbott Laboratories,
Novo Nordisk A/S, Sanofi, Eli Lilly and Company and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Republic of Korea Diabetes
Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197497-republic-of-korea-diabetes-care-devices-market-outlook-to-2018-
glucose-monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What is This Report About? 8
3 Diabetes Care Devices In Republic of Korea 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Constant, 2004-2018
10
3.3 Diabetes Care Devices Market, Republic of Korea, Revenue Mix ($m), 2011 11
3.4 Diabetes Care Devices Market, Republic of Korea, Category Contribution (%), 2011 12
3.5 Diabetes Care Devices, Republic of Korea, Company Share (2010-2011) 19
4 Glucose Monitoring In Republic of Korea 21
4.1 Glucose Monitoring, Market Segmentation 21
4.2 Glucose Monitoring Market, Republic of Korea, Revenue Mix ($m), 2011 22
4.3 Glucose Monitoring Market, Republic of Korea, Segment Contribution (%), 2011 23
4.4 Glucose Monitoring Overall Revenue, (2004-2018) 24
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 28
4.5 Glucose Monitoring Overall Volume (2004-2018) 30
4.5.1 Blood Glucose Meters, Volume (2004-2018) 34
4.6 Glucose Monitoring Average Price (2004-2018) 36
4.7 Glucose Monitoring Distribution Share (2010-2011) 37
4.8 Glucose Monitoring, Republic of Korea, Company Share (2010-2011) 38
5 Insulin Delivery In Republic of Korea 40

3. 5.1 Insulin Delivery, Market Segmentation 40
5.2 Insulin Delivery Market, Republic of Korea, Revenue Mix ($m), 2011 41
5.3 Insulin Delivery Market, Republic of Korea, Segment Contribution (%), 2011 42
5.4 Insulin Delivery Overall Revenue, (2004-2018) 43
5.4.1 Insulin Pens, Revenue (2004-2018) 47
5.4.2 Insulin Pumps, Revenue (2004-2018) 51
5.5 Insulin Delivery Overall Volume (2004-2018) 53
5.5.1 Insulin Pens, Volume (2004-2018) 57
5.5.2 Insulin Pumps, Volume (2004-2018) 61
5.6 Insulin Delivery Average Price (2004-2018) 63
5.7 Insulin Delivery Distribution Share (2010-2011) 64
5.8 Insulin Delivery, Republic of Korea, Company Share (2010-2011) 65
6 Overview of Key Companies in Republic of Korea Diabetes Care Devices Market 67
6.1 F. Hoffmann-La Roche Ltd. 67
6.1.1 Company Overview 67
6.1.2 Share in the Republic of Korea Diabetes Care Devices Market 68
6.2 LifeScan, Inc. 69
6.2.1 Company Overview 69
6.2.2 Share in the Republic of Korea Diabetes Care Devices Market 69
6.3 Abbott Laboratories 70
6.3.1 Company Overview 70
6.3.2 Share in the Republic of Korea Diabetes Care Devices Market 70
6.4 Novo Nordisk A/S 71
6.4.1 Company Overview 71
6.4.2 Share in the Republic of Korea Diabetes Care Devices Market 71
6.5 Sanofi 72
6.5.1 Company Overview 72
6.5.2 Share in the Republic of Korea Diabetes Care Devices Market 72
6.6 Eli Lilly and Company 73
6.6.1 Company Overview 73
6.6.2 Share in the Republic of Korea Diabetes Care Devices Market 73
6.7 ARKRAY, Inc. 74
6.7.1 Company Overview 74
6.8 Becton, Dickinson and Company 74
6.8.1 Company Overview 74
6.9 Bayer HealthCare AG 74
6.9.1 Company Overview 74
6.10 Terumo Corporation 75
6.10.1 Company Overview 75
6.11 Apex Biotechnology Corp. 75
6.11.1 Company Overview 75
6.12 Medtronic, Inc. 76

4. 6.12.1 Company Overview 76
6.13 Animas Corporation 76
6.13.1 Company Overview 76
6.14 Nipro Corporation 76
6.14.1 Company Overview 76
7 Diabetes Care Devices Market Pipeline Products 77
8 Appendix 80
8.1 Definitions of Markets Covered in the Report 81
8.1.1 Diabetes Care Devices 81
8.2 Research Methodology 83
8.3 Secondary Research 83
8.4 Primary Research 84
8.5 Models 84
8.6 Forecasts 85
8.7 Expert Panels 85
8.8 GlobalData Consulting 85
8.9 Currency Conversion 85
8.10 Contact Us 85
8.11 Disclaimer 86
1.1 List of Tables
Table 1: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Constant, 2004-
2018 10
Table 2: Diabetes Care Devices Market, Republic of Korea, Category Contribution (%), 2011 12
Table 3: Diabetes Care Devices, Republic of Korea, Cross-Segment Analysis, 2004-2018 14
Table 4: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Constant,
Historic, 2004-2011 16
Table 5: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Constant,
Forecast, 2011-2018 18
Table 6: Diabetes Care Devices, Republic of Korea, Company Share by Revenue ($m), USD
Constant, 2010-2011 20
Table 7: Glucose Monitoring Market, Republic of Korea, Segment Contribution (%), 2011 23
Table 8: Glucose Monitoring, Republic of Korea, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 25
Table 9: Glucose Monitoring, Republic of Korea, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 27
Table 10: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Revenue ($m)
USD Constant, Historic, 2004-2011 28
Table 11: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Revenue ($m)
USD Constant, Forecast, 2011-2018 29
Table 12: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment, Historic, 2004-2011
31

5. Table 13: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment, Forecast, 2011-
2018 33
Table 14: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Volume (Units),
Historic, 2004-2011 34
Table 15: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Volume (Units),
Forecast, 2011-2018 35
Table 16: Glucose Monitoring, Republic of Korea, Average Price ($), Historic, 2004-2011 36
Table 17: Glucose Monitoring, Republic of Korea, Average Price ($), Forecast, 2011-2018 36
Table 18: Glucose Monitoring, Republic of Korea, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 37
Table 19: Glucose Monitoring, Republic of Korea, Company Share by Revenue ($m), USD
Constant, 2010-2011 39
Table 20: Insulin Delivery Market, Republic of Korea, Segment Contribution (%), 2011 42
Table 21: Insulin Delivery, Republic of Korea, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 44
Table 22: Insulin Delivery, Republic of Korea, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 46
Table 23: Insulin Pens, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 48
Table 24: Insulin Pens, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 50
Table 25: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue ($m) USD
Constant, Historic, 2004-2011 51
Table 26: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue ($m) USD
Constant, Forecast, 2011-2018 52
Table 27: Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Historic, 2004-2011 54
Table 28: Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Forecast, 2011-2018
56
Table 29: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2004-2011
58
Table 30: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2011-2018
60
Table 31: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume (Units), Historic,
2004-2011 61
Table 32: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume (Units), Forecast,
2011-2018 62
Table 33: Insulin Delivery, Republic of Korea, Average Price ($), Historic, 2004-2011 63
Table 34: Insulin Delivery, Republic of Korea, Average Price ($), Forecast, 2011-2018 63
Table 35: Insulin Delivery, Republic of Korea, Distribution Share by Revenue ($m), USD Constant,
2010-2011 64
Table 36: Insulin Delivery, Republic of Korea, Company Share by Revenue ($m), USD Constant,
2010-2011 66

6. Table 37: Diabetes Care Devices Market Pipeline Products 77
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 9
Figure 2: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Constant, 2004-
2018 10
Figure 3: Diabetes Care Devices Market, Republic of Korea, Revenue Mix ($m), 2011 11
Figure 4: Diabetes Care Devices Market, Republic of Korea, Category Contribution (%), 2011 12
Figure 5: Diabetes Care Devices, Republic of Korea, Cross-Segment Analysis, 2004-2018 13
Figure 6: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Constant,
Historic, 2004-2011 15
Figure 7: Diabetes Care Devices, Republic of Korea, Overall Revenue ($m), USD Constant,
Forecast, 2011-2018 17
Figure 8: Diabetes Care Devices, Republic of Korea, Company Share (%), 2011 19
Figure 9: Glucose Monitoring, Market Segmentation 21
Figure 10: Glucose Monitoring Market, Republic of Korea, Revenue Mix ($m), 2011 22
Figure 11: Glucose Monitoring Market, Republic of Korea, Segment Contribution (%), 2011 23
Figure 12: Glucose Monitoring, Republic of Korea, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 24
Figure 13: Glucose Monitoring, Republic of Korea, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 26
Figure 14: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Revenue ($m)
USD Constant, Historic, 2004-2011 28
Figure 15: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Revenue ($m)
USD Constant, Forecast, 2011-2018 29
Figure 16: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment, Historic, 2004-
2011 30
Figure 17: Glucose Monitoring, Republic of Korea, Volume (Units) by Segment, Forecast, 2011-
2018 32
Figure 18: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Volume (Units),
Historic, 2004-2011 34
Figure 19: Blood Glucose Meters (Traditional Glucose Meters), Republic of Korea, Volume (Units),
Forecast, 2011-2018 35
Figure 20: Glucose Monitoring, Republic of Korea, Company Share (%), 2011 38
Figure 21: Insulin Delivery, Market Segmentation 40
Figure 22: Insulin Delivery Market, Republic of Korea, Revenue Mix ($m), 2011 41
Figure 23: Insulin Delivery Market, Republic of Korea, Segment Contribution (%), 2011 42
Figure 24: Insulin Delivery, Republic of Korea, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 43
Figure 25: Insulin Delivery, Republic of Korea, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 45
Figure 26: Insulin Pens, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment,

7. Historic, 2004-2011 47
Figure 27: Insulin Pens, Republic of Korea, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 49
Figure 28: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue ($m) USD
Constant, Historic, 2004-2011 51
Figure 29: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Revenue ($m) USD
Constant, Forecast, 2011-2018 52
Figure 30: Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Historic, 2004-2011 53
Figure 31: Insulin Delivery, Republic of Korea, Volume (Units) by Segment, Forecast, 2011-2018
55
Figure 32: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment, Historic, 2004-2011
57
Figure 33: Insulin Pens, Republic of Korea, Volume (Units) by Sub-Segment, Forecast, 2011-2018
59
Figure 34: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume (Units), Historic,
2004-2011 61
Figure 35: Insulin Pumps (Traditional Insulin Pumps), Republic of Korea, Volume (Units),
Forecast, 2011-2018 62
Figure 36: Insulin Delivery, Republic of Korea, Company Share (%), 2011 65
Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),Republic of Korea Diabetes Care
Devices Market, 2011 68
Figure 38: LifeScan, Inc., Company Share (%),Republic of Korea Diabetes Care Devices Market,
2011 69
Figure 39: Abbott Laboratories, Company Share (%),Republic of Korea Diabetes Care Devices
Market, 2011 70
Figure 40: Novo Nordisk A/S, Company Share (%),Republic of Korea Diabetes Care Devices
Market, 2011 71
Figure 41: Sanofi, Company Share (%),Republic of Korea Diabetes Care Devices Market, 2011 72
Figure 42: Eli Lilly and Company, Company Share (%),Republic of Korea Diabetes Care Devices
Market, 2011 73
Contact: sales@reportsandreports.com for more information.